HSCS
HeartSciences Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Buy
+36/100
Last price
3.82
▼ 0.54 (12.39%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.55
Prev close
4.36
Day high
3.88
Day low
3.39
Volume
599.72K
Market cap
$18.26M
P/E (TTM)
—
52W range
1.63 – 5.25
Day trading desk
Gap from prior close
-18.58%
Prior close 4.36
VWAP
3.73
+2.27% from price
Relative volume
8.26×
Unusually busy
Session range
33.44%
3.23 – 4.31
Position in range
55%
Mid range
ATR (14D)
0.58
15.21% of price
Prior day high
4.63
PDH
Prior day low
4.15
PDL
Bid / ask spread
—
Quote not published
Session volume
1.19M
Avg 144.42K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-6.91%
-8.9%
1M
+1.07%
-0.1%
3M
+38.10%
+33.6%
6M
+71.36%
+53.2%
YTD
+22.01%
+7.8%
1Y
+1.89%
-14.5%
3Y
-91.15%
-173.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HSCS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
751.23K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 22, 26 | SIMPSON ANDREW Chief Executive Officer |
STOCK | 425.00K | $0 | Direct |
| Nov 28, 25 | SIMPSON ANDREW Chief Executive Officer |
STOCK | 70.00K | $0 | Direct |
| Jul 29, 25 | HILZ MARK T Chief Operating Officer |
SELL | 4.42K | $15.62K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HILZ MARK T |
Chief Operating Officer | 4.79K | Sale |
SIMPSON ANDREW |
Chief Executive Officer | 499.38K | Stock Award(Grant) |
Fundamentals
Market cap$18.26M
Enterprise value$22.07M
Revenue (TTM)$4.52K
Gross profit$2.75K
EBITDA$-9.45M
Net income$-10.26M
EPS (TTM)$-3.21
Free cash flow$-2.24M
Total cash$29.91K
Total debt$4.00M
Book value / share$-0.52
Shares outstanding4.84M
Float3.10M
Short % of float0.87%
Dividend yield0.00%
Beta (5Y)1.78
Valuation & profitability ratios
Trailing P/E—
Forward P/E-2.15
PEG ratio—
Price / sales—
Price / book—
EV / revenue4,884.28
EV / EBITDA-2.34
Gross margin60.88%
Operating margin-139956.68%
Profit margin0.00%
Return on equity-1851.90%
Return on assets-116.44%
Debt / equity—
Current ratio0.14
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.32K | $4.35K | $18.60K | $5.15K | -0.7% |
| Operating revenue | $4.32K | $4.35K | $18.60K | $5.15K | -0.7% |
| Cost of revenue | $1.77K | $1.88K | $6.08K | $2.80K | -6.0% |
| Gross profit | $2.55K | $2.47K | $12.52K | $2.35K | +3.3% |
| Research & development | $2.84M | $4.39M | $2.88M | $2.46M | -35.3% |
| Selling, general & admin | $5.58M | $3.97M | $3.44M | $3.65M | +40.5% |
| Total operating expense | $8.42M | $8.36M | $6.32M | $6.12M | +0.7% |
| Operating income | -$8.41M | -$8.35M | -$6.31M | -$6.11M | -0.7% |
| Net interest income | -$753.04K | -$500.45K | -$354.08K | -$243.17K | -50.5% |
| Pre-tax income | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -4.3% |
| Net income | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -4.3% |
| Net income to common | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -4.3% |
| Basic EPS | -3.48 | -9.34 | -18.74 | -80.00 | +62.7% |
| Diluted EPS | -3.48 | -9.34 | -18.74 | -80.00 | +62.7% |
| EBIT | -$8.39M | -$8.26M | -$6.25M | -$6.11M | -1.5% |
| EBITDA | -$8.26M | -$8.14M | -$6.16M | -$5.98M | -1.5% |
| Basic shares | 2.63M | 938.26K | 352.52K | 79.51K | +179.8% |
| Diluted shares | 2.63M | 938.26K | 352.52K | 79.51K | +179.8% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.66M | $1.10M | $5.81M | $1.66M | — | +50.9% |
| Cash & short-term investments | $1.66M | $1.10M | $5.81M | $1.66M | — | +50.9% |
| Accounts receivable | $0 | $4.35K | $0 | $0 | — | -100.0% |
| Inventory | $655.63K | $650.27K | $629.18K | $676.36K | — | +0.8% |
| Total current assets | $2.58M | $2.17M | $7.35M | $2.70M | — | +18.9% |
| Property, plant & equipment | $307.38K | $435.18K | $559.97K | $590.65K | — | -29.4% |
| Goodwill & intangibles | $2.37M | $1.62M | $1.59M | $0 | — | +46.8% |
| Total assets | $5.26M | $4.22M | $9.50M | $3.29M | — | +24.6% |
| Total current liabilities | $4.86M | $3.70M | $1.75M | $1.83M | — | +31.3% |
| Current debt | $3.62M | $2.55M | $500.00K | $500.00K | — | +42.0% |
| Long-term debt | — | — | — | $500.00K | $4.44M | — |
| Total debt | $3.94M | $2.99M | $1.04M | $1.57M | — | +31.9% |
| Total liabilities | $5.04M | $4.02M | $2.19M | $3.06M | — | +25.4% |
| Retained earnings | -$85.27M | -$76.13M | -$67.36M | -$60.76M | — | -12.0% |
| Shareholder equity | $226.06K | $205.17K | $7.32M | $230.56K | — | +10.2% |
| Working capital | -$2.28M | -$1.53M | $5.60M | $863.69K | — | -48.7% |
| Net tangible assets | -$2.15M | -$1.41M | $5.73M | $230.56K | — | -52.1% |
| Shares issued | 3.18M | 1.12M | 676.60K | 101.18K | — | +184.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -4.3% |
| Depreciation & amortisation | $131.35K | $127.96K | $95.13K | $135.45K | +2.7% |
| Stock-based compensation | $1.31M | $249.88K | $405.02K | $248.31K | +425.2% |
| Change in working capital | -$1.08M | $517.89K | -$504.36K | $65.45K | -308.8% |
| Operating cash flow | -$7.43M | -$7.41M | -$6.07M | -$5.77M | -0.2% |
| Capital expenditure | -$44.45K | -$30.19K | -$125.27K | -$18.31K | -47.3% |
| Investing cash flow | -$44.45K | -$30.19K | -$125.27K | -$18.31K | -47.3% |
| Financing cash flow | $8.03M | $2.73M | $10.34M | $6.53M | +193.7% |
| Free cash flow | -$7.47M | -$7.44M | -$6.20M | -$5.79M | -0.4% |
| End cash position | $1.66M | $1.10M | $5.81M | $1.66M | +50.9% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-01-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $2.10K | $0 | $0 | $2.42K | $1.90K | — | — |
| Operating revenue | $2.10K | $0 | $0 | $2.42K | $1.90K | — | — |
| Cost of revenue | $760 | $0 | $0 | $1.01K | $760 | — | — |
| Gross profit | $1.34K | $0 | $0 | $1.41K | $1.14K | — | — |
| Research & development | $906.63K | $476.20K | $638.58K | $727.03K | $997.21K | — | +90.4% |
| Selling, general & admin | $2.03M | $2.06M | $1.29M | $1.35M | $878.05K | — | -1.3% |
| Total operating expense | $2.94M | $2.54M | $1.93M | $2.07M | $1.88M | — | +15.9% |
| Operating income | -$2.94M | -$2.54M | -$1.93M | -$2.07M | -$1.87M | — | -15.9% |
| Net interest income | -$235.26K | -$228.31K | -$61.51K | -$279.53K | -$183.69K | — | -3.0% |
| Pre-tax income | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | — | -15.3% |
| Net income | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | — | -15.3% |
| Net income to common | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | — | -15.3% |
| Basic EPS | -0.86 | — | -0.63 | -0.85 | -1.58 | -2.57 | — |
| Diluted EPS | -0.86 | — | -0.63 | -0.85 | -1.58 | -2.57 | — |
| EBIT | -$2.94M | -$2.52M | -$1.92M | -$2.07M | -$1.87M | — | -16.4% |
| EBITDA | -$2.90M | -$2.49M | -$1.89M | -$2.04M | -$1.84M | — | -16.6% |
| Basic shares | 3.67M | — | 3.16M | 2.78M | 1.30M | 986.06K | — |
| Diluted shares | 3.67M | — | 3.16M | 2.78M | 1.30M | 986.06K | — |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $29.91K | $1.66M | $3.40M | $1.95M | $2.79M | — | -98.2% |
| Cash & short-term investments | $29.91K | $1.66M | $3.40M | $1.95M | $2.79M | — | -98.2% |
| Accounts receivable | — | $0 | $0 | $0 | $0 | $4.35K | — |
| Inventory | $402.99K | $655.63K | $657.28K | $657.28K | $649.51K | — | -38.5% |
| Total current assets | $811.77K | $2.58M | $5.10M | $3.79M | $4.42M | — | -68.6% |
| Property, plant & equipment | $272.85K | $307.38K | $341.38K | $374.62K | $403.50K | — | -11.2% |
| Goodwill & intangibles | $2.65M | $2.37M | $2.11M | $1.83M | $1.62M | — | +11.8% |
| Total assets | $3.74M | $5.26M | $7.55M | $6.00M | $6.44M | — | -29.0% |
| Total current liabilities | $5.63M | $4.86M | $4.27M | $1.57M | $3.01M | — | +15.9% |
| Current debt | $3.72M | $3.62M | $3.10M | $500.00K | $1.54M | — | +2.8% |
| Long-term debt | — | — | $421.56K | — | — | — | — |
| Total debt | $4.00M | $3.94M | $3.87M | $876.24K | $1.95M | — | +1.7% |
| Total liabilities | $5.77M | $5.04M | $4.90M | $1.81M | $3.30M | — | +14.6% |
| Retained earnings | -$88.44M | -$85.27M | -$82.52M | -$80.53M | -$78.18M | — | -3.7% |
| Shareholder equity | -$2.03M | $226.06K | $2.65M | $4.18M | $3.14M | — | -999.4% |
| Working capital | -$4.82M | -$2.28M | $829.92K | $2.23M | $1.40M | — | -111.6% |
| Net tangible assets | -$4.69M | -$2.15M | $537.83K | $2.35M | $1.52M | — | -118.3% |
| Shares issued | 3.90M | 3.18M | 3.18M | 3.07M | 2.28M | — | +22.6% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | — | -15.3% |
| Depreciation & amortisation | $34.53K | $34.00K | $33.24K | $32.44K | $31.68K | — | +1.5% |
| Stock-based compensation | $738.89K | $324.84K | $376.10K | $436.88K | $174.56K | — | +127.5% |
| Change in working capital | $727.36K | -$133.92K | $13.30K | -$746.27K | -$214.56K | — | +643.1% |
| Operating cash flow | -$1.32M | -$1.68M | -$1.46M | -$2.33M | -$1.95M | — | +21.3% |
| Capital expenditure | -$280.11K | — | -$27.87K | -$15.77K | -$814 | -$7.81K | — |
| Investing cash flow | -$280.11K | $0 | -$27.87K | -$15.77K | -$814 | — | — |
| Financing cash flow | -$27.94K | -$63.67K | $2.94M | $1.51M | $3.65M | — | +56.1% |
| Free cash flow | -$1.60M | -$1.68M | -$1.49M | -$2.35M | -$1.95M | — | +4.6% |
| End cash position | $29.91K | $1.66M | $3.40M | $1.95M | $2.79M | — | -98.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | -0.72 | -0.86 | -19.4% |
| Apr 2026 | -0.67 | -0.87 | -29.8% |
| Jan 2026 | -0.88 | -0.63 | +28.4% |
| Oct 2025 | -1.28 | -0.85 | +33.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.62 | 1 | $0 | -100.0% |
| Next quarter | -0.61 | 1 | $5.00K | 0.0% |
| Current year | -2.46 | 1 | $17.10K | +295.8% |
| Next year | -1.75 | 1 | $3.15M | +18,321.1% |
Analyst targets & ownership
Mean target$12.00
High target$12.00
Low target$12.00
Implied upside214.16%
Analyst count1
ConsensusBUY
Strong buy / Buy1 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders15.65%
Held by institutions3.20%
Institutions holding17
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
4.29
-10.88% from price
SMA 20
4.20
-10.22% from price
SMA 50
3.22
+17.11% from price
SMA 100
2.74
+39.32% from price
SMA 200
2.69
+40.27% from price
EMA 12
4.18
-8.55% from price
EMA 26
3.94
-3.02% from price
EMA 50
3.51
+8.78% from price
RSI (14)
47.8
Neutral
MACD (12,26,9)
0.24
Hist -0.12
ATR (14)
0.58
15.41% of price
Realised vol 30D
131.9%
Annualised
Bollinger upper
5.21
20, 2σ
Bollinger lower
3.19
20, 2σ
50 / 200 cross
Golden
3.22 vs 2.69
Trend bias
Above 200
+40.27%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.15
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
131.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-55.5%
Peak to trough
Max drawdown 5Y
-99.5%
Peak to trough
ATR 14
0.58
15.41% of price
Beta (reported)
1.78
5Y monthly, from filing
Short interest
Shares short
39.86K
Prior 50.68K
Change vs prior
-21.4%
Shorts covering
% of float
0.87%
Normal
% of shares out
0.83%
Against total outstanding
Days to cover
0.3
Liquid
Float
3.10M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 24, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Dec 22, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Oct 1, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Mar 18, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Dec 18, 24 | Maxim Group | MAINTAINED | Buy | Buy |
| Sep 23, 24 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Jan 30, 23 | Ascendiant Capital | INITIATED | — | Buy |
| Dec 19, 22 | Maxim Group | MAINTAINED | — | Buy |
| Nov 9, 22 | Maxim Group | INITIATED | — | Buy |
| Aug 8, 22 | Benchmark | INITIATED | — | Speculative Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split1:100
Split dateMay 17, 2024
SEC filings
Proxy Statements
PRER14A · 2026-10-06
Corporate Changes & Voting Matters
8-K · 2026-10-02
Proxy Statements
DEFA14A · 2026-09-30
Offering Registrations
S-3 · 2026-09-25
Proxy Statements
DEFA14A · 2026-09-24
Proxy Statements
DEFA14A · 2026-09-21
Proxy Statements
PRER14A · 2026-09-18
Corporate Changes & Voting Matters
8-K · 2026-09-17
Headlines
Fortitude Doubles Down on Zcash Mining With $100M BITMAIN Commitment
CryptoProwl · 18h ago
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
GlobeNewswire · 19h ago
Top Premarket Decliners
MT Newswires · 20h ago
HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million
MT Newswires · 13d ago
Former Hut 8 CEO To Lead Crypto Miner Fortitude
CryptoProwl · 20d ago
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
GlobeNewswire · 22d ago
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
Zacks · 22d ago
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
GlobeNewswire · 49d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.